Labshake search
Citations for Tocris :
151 - 200 of 1076 citations for 4 nitro 5 ethyl 2 methylpyridine n oxide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Neuroscience 2020Quote: ... WIN 55,212-2 (WIN, 0.5 µg/0.5-µL infusion/hemisphere; n = 11; Tocris Bioscience, Minneapolis, MN) or VEH (10% DMSO ...
-
bioRxiv - Neuroscience 2019Quote: N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251, 3µM) (Tocris) was dissolved in ethanol and then added in the external solution at a final concentration of ethanol of 0.015% ...
-
bioRxiv - Molecular Biology 2019Quote: ... or washed three times in water and stained with 10 μM (5Z)-5-[(3,5-Difluoro-4-hydroxyphenyl)methylene]-3,5-dihydro-2-methyl-3-(2,2,2-trifluoroethyl)-4H-imidazol-4-one (DFHBI-1T)(Tocris) in 50 mM KCl ...
-
bioRxiv - Neuroscience 2020Quote: ... and D-2-amino-5-phosphonovalerate (APV, 25 µM, Tocris) in order to block synaptic transmission and ensure that the observed events were due to the stimulation only ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid (APV, 50 μM, Tocris) was added to the ACSF to avoid the unintended N-methyl-D-aspartate receptor (NMDAR ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2023Quote: ... Step 2: synaptic blockers (50µm DL-AP-5 (Tocris #0105), 40µm L-AP4 (Tocris #0103) ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 L-AP4 (Alomone Labs) and 2-5 ACET (Tocris) (Park et al. ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Neuroscience 2023Quote: ... anisomycin and N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM-251) were purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... CACNA1A+/− networks on MEA at DIV51 were treated with 20 µM 4-aminopyridine (4-AP; Tocris, #504-24-5) and recorded for 30 minutes after the compound was added ...
-
bioRxiv - Neuroscience 2019Quote: ... and 5 µg/ml Bovine Serum Albumin) containing 4 µM CHIR99021 (Tocris), 3 µM SB431542 (Sigma) ...
-
bioRxiv - Cell Biology 2020Quote: ... 5 mg/kg BW for 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN, Tocris), or vehicle ...
-
bioRxiv - Genomics 2023Quote: ... 2,3-Bis(4-hydroxyphenyl)propionitrile (DPN, 5 mg/kg body weight, Tocris) and 4-(2-(3,5-dimethylisoxazol-4-yl)-1H-indol-3-yl)phenol (DIP ...
-
bioRxiv - Cell Biology 2023Quote: ... Neurosensor 510 (7-(Diethylamino)-4-(4-methoxyphenyl)-2-oxo-2H-1-benzopyran-3-carboxaldehyde) was purchased from (Tocris).
-
bioRxiv - Physiology 2024Quote: ... 4-(3-chloro-pyridin-2-yl)-piperazine-1-carboxylic acid (4-tert-butyl-phenyl)-amide (BCTC, Tocris #3875) 10 mM in DMSO ...
-
bioRxiv - Neuroscience 2019Quote: ... a final group of animals (n=4) received a DBB infusion of K-234 (1 nmol/0.5 µl/per side; Tocris Bioscience ...
-
bioRxiv - Physiology 2022Quote: ... BPTU (1-(2-(2-(tert-butyl)phenoxy)pyridin-3-yl)-3-(4-(trifluoromethoxy) phenyl) urea was from Tocris Bioscience.
-
bioRxiv - Neuroscience 2021Quote: ... and 40 µM D(−)-2-amino-5-phosphonovaleric acid (APV; Tocris) and 50 nM of rat CGRP or vehicle ...
-
bioRxiv - Neuroscience 2021Quote: ... DL-2-Amino-5-phosphonopentanoic acid (DL-AP5, 40 µM, Tocris), bicuculline methiodide (Bic ...
-
bioRxiv - Genomics 2022Quote: ... and 100μM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) overnight to reduce endogenous neuronal activity prior to stimulation ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 mM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris) to block AMPA and NMDA receptors ...
-
bioRxiv - Neuroscience 2022Quote: ... D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105), and BI2536 (Selleckchem #S1109) ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-phosphonopetanoate (D-AP5, 50 μM; Tocris) were added to inhibit GABAergic or glutamatergic synaptic transmission ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50µM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris 0106). Neurons were voltage clamped at -70mV ...
-
bioRxiv - Biochemistry 2024Quote: ... 25 μM d-(−)-2-amino-5-phosphonovaleric acid (D-AP5, Tocris), and 100 μM picrotoxin (Nacalai Tesque ...
-
bioRxiv - Cell Biology 2020Quote: ... the γ-secretase inhibitor (2S)-N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine1,1-dimethylethyl ester (DAPT) (Tocris) was added at a concentration of 5 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience), were freshly diluted and bath-applied through the perfusion line 10 minutes before recording ...
-
bioRxiv - Neuroscience 2021Quote: ... washed with 4-5 ml ice cold PBS supplemented with 0.5 % BSA (Tocris), and collected by centrifugation for 10 min (300 g) ...
-
bioRxiv - Neuroscience 2022Quote: ... and (2S)-1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanone hydrochloride (TCS-OX2-29) were purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... 4-(4-,9-diethoxy-1,3-dihydro-1-oxo-2H-benz[f]isoindol-2-yl)-N-(phenylsulfonyl) benzeneacetamide (GW627368X 3 µM, Tocris); 6-Isopropoxy-9-xanthone-2-carboxylic acid (AH6809 ...
-
bioRxiv - Neuroscience 2023Quote: Pharmacological inhibition of AQP4 was achieved using TGN-020 (N-1,3,4-thiadiazol-2-yl-3-pyridinecarboxamide, Tocris Bioscience, UK). Unless otherwise stated ...
-
bioRxiv - Neuroscience 2022Quote: ... animals were treated with the selective positive allosteric modulator (PAM) of mGluR5 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; Tocris, UK) that was diluted in saline solution containing 5-10% final concentration of DMSO and polyethylene glycol 400 (DMSO ...
-
bioRxiv - Neuroscience 2019Quote: ... and DL-2-amino-5-phosphonopentanoic acid (AP5, 50 μM; Tocris Bioscience). Data files were recorded in two-minute increments in order to establish the baseline recording before bath application of ethanol ...
-
bioRxiv - Cell Biology 2019Quote: ... and 50µM D-(-)-2-amino-5-phosphonopentanoic (D-AP5 or APV; Tocris) buffered to pH 7.4 at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2019Quote: ... 7,8-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one (DHF, 10 µM) (Tocris), 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-butadiene (U0126 ...
-
bioRxiv - Cell Biology 2022Quote: At day 0 cells were treated with 5 nM 4-Hydroxytamoxifen (+HOT) (Tocris, 3412) or with vehicle (-HOT ...
-
bioRxiv - Cell Biology 2022Quote: ... The FFA2R antagonist CATPB ((S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)-phenyl) butanoic acid) was from Tocris (Britsol, UK).
-
bioRxiv - Neuroscience 2022Quote: ... was inserted into the guide cannula and a Hamilton Syringe was used to administrate 1 μL of 2 mM pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic acid (PPADS, Tocris, 0625), 1.5 μg/μL S961 (Phoenix Pharmaceuticals ...
-
bioRxiv - Genomics 2021Quote: ... neurons were made quiescent for 2 hours with 100 μM D-2- amino-5-phosphonopentanoic acid (D-AP5; Tocris #0106) and 1 μM tetrodotoxin (TTX ...